News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Ranbaxy Laboratories: FDA Issues Will Take Long Time to Resolve
November 9, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW DELHI -- Ranbaxy Laboratories Ltd. will take "a long time" to resolve issues with the U.S. Food and Drug Administration, Chief Executive Atul Sobti said Monday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Asia
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
GLP-1
Novo Sues Hims & Hers Over Compounded Version of Oral Wegovy Pill
February 9, 2026
·
2 min read
·
Tristan Manalac
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
February 9, 2026
·
6 min read
·
Claire Davies
Policy
FDA Policy Tracker 2026: Priority Vouchers Questioned, PRVs Return
February 9, 2026
·
5 min read
·
Heather McKenzie
GLP-1
Makary Blasts ‘Illegal Copycat Drugs’ as Hims Launches Compounded Wegovy Pill
February 6, 2026
·
1 min read
·
Tristan Manalac
